Neutralizing and hemagglutination-inhibiting antibodies have been found to persist 16 to 19 years following a single dose of 17D strain yellow fever vaccine in retiring Navy and Marine personnel who gave no evidence of other Group B arthropod-borne virus exposure.
Epidemiologist, Pan American Sanitary Bureau, Washington, D. C.